Today: 20 May 2026
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings
8 February 2026
1 min read

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

New York, February 7, 2026, 21:20 EST — Market closed

Shares of MACOM Technology Solutions Holdings Inc ended Friday’s session up 3.5% at $235.87, with an intraday high reaching $240.85. Traders are still working through the chipmaker’s strong quarterly results and a flurry of fresh filings from regulators as Monday approaches.

The rally’s significance? MACOM is now a direct proxy for high-speed connectivity demand in data centers—the essential plumbing behind cloud operators’ growing compute. But the stock also lives in that tricky “good-news, high-multiple” tech zone, a group that tends to get tossed around whenever interest rates shift.

MACOM posted fiscal Q1 revenue of $271.6 million on Thursday, with adjusted EPS landing at $1.02. Looking to Q2, the company expects revenue between $281 million and $289 million and adjusted earnings ranging from $1.05 to $1.09 a share. “We delivered a solid start to fiscal year 2026,” CEO Stephen Daly said. MACOM

During the earnings call, management highlighted a book-to-bill ratio of 1.3, indicating stronger demand than shipments. They bumped up their full-year outlook for data center revenue growth, now expecting 35%–40% instead of the previous 20%. Executives also mentioned a $55 million satellite-communications program affected by scheduling changes, and noted that $161 million of convertible notes are set to be repaid in cash come March.

Stifel analyst Tore Svanberg wasted no time, bumping up his price target for the stock to $255 from $215 while sticking with a “Buy” call, a Friday report showed. Investing.com

Fidelity’s FMR LLC disclosed in a Friday filing that it held roughly 8.03 million shares of MACOM, representing a 10.7% stake in the company as of Jan. 30.

In a separate Form 144, shareholder Susan Ocampo signaled plans for a possible sale of as many as 100,000 shares, targeting Feb. 6 as the estimated date. These filings only indicate an intent—they don’t confirm that a sale will actually happen.

Still, it’s not a straight shot up. MACOM’s rally has dragged shares near new peaks, but even a slight move in rates could knock “growth” chip names lower. Investors are eyeing whether data center bookings hold up after the first earnings pop, and if satellite program schedules will face more delays.

Looking ahead, the calendar gets busy with macro data. The U.S. January jobs report hits Wednesday, Feb. 11, while January’s CPI lands Friday, Feb. 13. Remember, U.S. markets will be closed Monday, Feb. 16, for Washington’s Birthday.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Zhongji Innolight stock slides nearly 4% into China’s Monday open — what traders watch next
Previous Story

Zhongji Innolight stock slides nearly 4% into China’s Monday open — what traders watch next

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026
Next Story

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026

Go toTop